Sarli, Macarena <br/><br/>
A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.  [electronic resource] 

 -  PloS one  2020 
 - e0229301 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0229301  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplasma marginale--immunology<br/>Animals<br/>Antibodies, Bacterial--immunology<br/>Bacterial Vaccines--genetics<br/>Cattle<br/>Immunization<br/>Recombinant Proteins--genetics<br/>Type IV Secretion Systems--genetics<br/>Virulence--immunology